PFND   $0.0007  -30.00% Market Closed

PATHFINDER CELL THERAPY
Total Cash 4.00K
totalCashPerShare 0.0
EBITDA -772.00K
Total Debt 5.41M
quickRatio 0.001
currentRatio 0.001
Total Revenue
debtToEquity
Revenue/Share
ROA -8.8876095
ROE
grossProfits
freeCashflow -223.00K
operatingCashflow -579.00K
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 5.41M
forwardPE
floatShares
sharesOutstanding 667.16M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.0
heldPercentInstitutions 0.0
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue -0.01
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -1.08M
trailingEps 0.0
forwardEps
enterpriseToEbitda -7.01
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 0
lastUpdated Nov. 7, 2024, 1:33 a.m.